This bill adds several new sections to chapter 69.50 RCW to change how licensed cannabis businesses package products, track plants, accept items for recycling or disposal, and design vapor product batteries. It directs the relevant regulatory board to adopt rules allowing certain solid edible cannabis products to be sold in a single multiuse resealable outer package without individual inner wraps if the outer package meets specified child-resistant federal standards (16 C.F.R. Sec. 1700.15 and 1700.20 and the Poison Prevention Packaging Act), to allow cannabis concentrates and vapor products to be packaged in unit and multiunit sizes up to the maximum amount sellable in a single transaction (removing one-gram or smaller unit restrictions), and to permit producers to use digital batch-level identification in an electronic seed-to-sale system instead of affixing single-use physical tags to every plant. The bill also requires rules that preserve prohibitions on consumption and possession of open cannabis packages on retail premises while creating a limited exception allowing retailers to accept open packages, used vapor devices, and used batteries solely for recycling or safe disposal under secure, nonpublic handling and no-resale requirements. It requires rules for retail vapor products to use devices with batteries designed to be removable by consumers or by recycling personnel using common tools, with technical standards, coordination with battery recycling programs, a one-year phase-in, and narrow exceptions where removable-battery designs are not technologically feasible or to preserve access for qualifying patients. These are rulemaking and regulatory procedural changes added to existing law rather than creation of new crimes or civil penalties; enforcement is to use existing authorities and licensing/regulatory provisions under chapter 69.50 RCW. The bill sets deadlines: rules for packaging, concentrates/vapor sizing, plant tracking, and retailer returns must be adopted within 12 months and complied with after 24 months; battery/removable-battery rules must be adopted within 24 months with compliance after 36 months and an allowed one-year phase-in. The text provided does not identify the board by name, does not state the act’s effective date, and does not define terms such as "electronic seed-to-sale system," "digital batch-level identification," "qualifying patients," or current statutory limits referenced, so those details are uncertain from the extracted facts.

If enacted, producers and retailers would get more flexible packaging and tracking options: edible solids could be sold loose inside a single resealable, child‑resistant outer package and concentrates/vapor products could be sold in larger unit or multiunit packages up to the daily purchase limit, while producers could stop putting single‑use physical tags on every plant and instead use electronic batch‑level identification. That will likely reduce some costs and waste from inner wrappers and plant tags, but will also create new upfront costs and operational responsibilities for businesses to redesign packaging, set up secure handling for voluntary retail take‑backs of open packages and used devices, and meet new digital tracking and labeling rules. Vapor device makers will face pressure to produce designs with user‑removable batteries (or secure narrow exceptions), which may raise manufacturing costs and affect product availability, and retailers who accept used batteries will need secure containers and coordination with recycling programs to avoid fire risks. The state board (unnamed in the text) must write implementing rules on firm timelines and enforcement will use existing licensing tools rather than new criminal penalties, giving businesses 24 months (36 months for the battery rule, with a one‑year phase‑in) after the act’s effective date to comply. Important implementation details are missing from the provided text — the act’s effective date, the identity of the board, the current THC and daily purchase limits, and precise definitions of electronic systems and qualifying patients — so exact deadlines, scope, and how some exceptions will work remain unclear.